- Identifying the patient at risk for post-transplant lymphoproliferative disorderS M Cockfield
Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Canada
Transpl Infect Dis 3:70-8. 2001..It is hoped that implementation of such strategies will render early PTLD a preventable complication of transplantation...
- Serologic responses to hepatitis C virus in solid organ transplant recipientsJ K Preiksaitis
Medical Microbiology and Public Health, University of Alberta Hospitals, Edmonton, Canada
Transplantation 64:1775-80. 1997..We sought to determine the historical incidence of donor- and transfusion-acquired HCV infection in kidney transplant (RTx) and heart transplant (HTx) recipients at our center and to study the kinetics of seroconversion to HCV...
- Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for causeB Sis
Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada
Am J Transplant 7:1743-52. 2007..The remaining 27%, mostly BD, may be a different disease or a stage in which A and C are undetectable...